(Q39382195)

11 September 2017

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors (English)

1 reference

11 September 2017

0 references

1 reference

ChEBI release 2020-05-28

3

1 reference

11 September 2017

6

Kuo-Hsiung Lee

1 reference

11 September 2017

Lian-Qi Sun

1

1 reference

11 September 2017

Bingjie Qin

2

1 reference

11 September 2017

Keduo Qian

4

1 reference

11 September 2017

Chin-Ho Chen

5

1 reference

11 September 2017

Lan Xie

7

1 reference

11 September 2017

language of work or name

English

0 references

publication date

24 February 2012

1 reference

Bioorganic & Medicinal Chemistry Letters

11 September 2017

1 reference

11 September 2017

22

1 reference

11 September 2017

7

1 reference

11 September 2017

2376-2379

1 reference

Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

Etravirine and rilpivirine: nonnucleoside reverse transcriptase inhibitors with activity against human immunodeficiency virus type 1 strains resistant to previous nonnucleoside agents

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

Antiretroviral therapy: state of the HAART.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

Turning the Tide Against HIV

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309038

AIDS: let science inform policy

2 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22406117

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BMCL.2012.02.055

1 reference

11 September 2017

1 reference

11 September 2017

PubMed publication ID

22406117

1 reference